609 related articles for article (PubMed ID: 21584865)
1. Striatal dopamine D1 and D2 receptors: widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity.
Gross NB; Duncker PC; Marshall JF
Synapse; 2011 Nov; 65(11):1144-55. PubMed ID: 21584865
[TBL] [Abstract][Full Text] [Related]
2. Running wheel exercise ameliorates methamphetamine-induced damage to dopamine and serotonin terminals.
O'Dell SJ; Galvez BA; Ball AJ; Marshall JF
Synapse; 2012 Jan; 66(1):71-80. PubMed ID: 21953518
[TBL] [Abstract][Full Text] [Related]
3. Striatal dopamine and glutamate receptors modulate methamphetamine-induced cortical Fos expression.
Gross NB; Marshall JF
Neuroscience; 2009 Jul; 161(4):1114-25. PubMed ID: 19374938
[TBL] [Abstract][Full Text] [Related]
4. Interactions of dopamine D1 and D2 receptor antagonists with D-methamphetamine-induced hyperthermia and striatal dopamine and serotonin reductions.
Broening HW; Morford LL; Vorhees CV
Synapse; 2005 May; 56(2):84-93. PubMed ID: 15714503
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ
J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534
[TBL] [Abstract][Full Text] [Related]
6. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
Mela F; Marti M; Bido S; Cenci MA; Morari M
Neurobiol Dis; 2012 Jan; 45(1):573-82. PubMed ID: 22001605
[TBL] [Abstract][Full Text] [Related]
7. Cortical ionotropic glutamate receptor antagonism protects against methamphetamine-induced striatal neurotoxicity.
Gross NB; Duncker PC; Marshall JF
Neuroscience; 2011 Dec; 199():272-83. PubMed ID: 21946008
[TBL] [Abstract][Full Text] [Related]
8. Impaired object recognition memory following methamphetamine, but not p-chloroamphetamine- or d-amphetamine-induced neurotoxicity.
Belcher AM; O'Dell SJ; Marshall JF
Neuropsychopharmacology; 2005 Nov; 30(11):2026-34. PubMed ID: 15900317
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptor regulation of Ca2+ levels in individual isolated nerve terminals from rat striatum: comparison of presynaptic D1-like and D2-like receptors.
Wu J; Dougherty JJ; Nichols RA
J Neurochem; 2006 Jul; 98(2):481-94. PubMed ID: 16805841
[TBL] [Abstract][Full Text] [Related]
10. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
Hu XT; White FJ
Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
[TBL] [Abstract][Full Text] [Related]
11. Running wheel exercise before a binge regimen of methamphetamine does not protect against striatal dopaminergic damage.
O'dell SJ; Marshall JF
Synapse; 2014 Sep; 68(9):419-25. PubMed ID: 24899064
[TBL] [Abstract][Full Text] [Related]
12. Methamphetamine influences on recognition memory: comparison of escalating and single-day dosing regimens.
Belcher AM; Feinstein EM; O'Dell SJ; Marshall JF
Neuropsychopharmacology; 2008 May; 33(6):1453-63. PubMed ID: 17637607
[TBL] [Abstract][Full Text] [Related]
13. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
Shuto T; Seeman P; Kuroiwa M; Nishi A
Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
[TBL] [Abstract][Full Text] [Related]
14. Effects of dopamine antagonists on methamphetamine-induced dopamine release in high and low alcohol preference rats.
Nishiguchi M; Kinoshita H; Kasuda S; Takahashi M; Yamamura T; Matsui K; Ouchi H; Minami T; Hishida S; Nishio H
Toxicol Mech Methods; 2010 Mar; 20(3):127-32. PubMed ID: 20163290
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
16. Methylone-induced hyperthermia and lethal toxicity: role of the dopamine and serotonin transporters.
Piao YS; Hall FS; Moriya Y; Ito M; Ohara A; Kikura-Hanajiri R; Goda Y; Lesch KP; Murphy DL; Uhl GR; Sora I
Behav Pharmacol; 2015 Jun; 26(4):345-52. PubMed ID: 25794333
[TBL] [Abstract][Full Text] [Related]
17. Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine.
Ke JJ; Chen HI; Jen CJ; Kuo YM; Cherng CG; Tsai YP; Ho MC; Tsai CW; Yu L
Toxicol Appl Pharmacol; 2008 Mar; 227(2):239-47. PubMed ID: 18076959
[TBL] [Abstract][Full Text] [Related]
18. Neurotoxic methamphetamine regimen severely impairs recognition memory in rats.
Schröder N; O'Dell SJ; Marshall JF
Synapse; 2003 Aug; 49(2):89-96. PubMed ID: 12740864
[TBL] [Abstract][Full Text] [Related]
19. Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists.
O'Dell SJ; Weihmuller FB; Marshall JF
J Neurochem; 1993 May; 60(5):1792-9. PubMed ID: 8473897
[TBL] [Abstract][Full Text] [Related]
20. Effects of intrastriatal dopamine D1 or D2 antagonists on methamphetamine-induced egocentric and allocentric learning and memory deficits in Sprague-Dawley rats.
Gutierrez A; Regan SL; Hoover CS; Williams MT; Vorhees CV
Psychopharmacology (Berl); 2019 Jul; 236(7):2243-2258. PubMed ID: 30919007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
